Dr. Hui Cai was the 2009 Chair of the ACS San Diego Section. SheÂ is Vice President of Business Development at WuXi AppTec (NYSE: WX), one of the world’s most reputable providers of comprehensive and integrated pharmaceutical R&D services with 4200 employees, and FDA/EXMA inspected facilities in the US and China. She brought to WXÂ a broad portfolio of expertise in strategic planning, business development, and portfolio management as President of Inflexion BioPartners and Vice President of Corporate Development at HUYA Bioscience. Prior to that, Dr. Cai spent ten years at Johnson & Johnson Pharmaceutical Research and Development, co-leading multiple small molecule drug discovery programs. She is a co-author and co-inventor of over 40 scientific publications and issued or pending patents. Dr. Cai was appointed by the Mayor of San Diego in 2002 to serve as a Commissioner at City of San Diego Science and Technology Commission. She was also Chairwoman of Board at Sino-American Biomedical and Pharmaceutical Professionals Association. Dr. Cai received her BS and MS in Chemistry from Peking University, PhD from The Scripps Research Institute, and MBA from the UCSD Rady School of Management as a DLA Piper – Athena FlexMBA Scholar.